Marta Batus, MD

Below is a list of scientific publications for which this practitioner was either the primary author or a contributor. Citations come from PubMed, a database of biomedical literature, life science journals and online books. PubMed is a service of the US Library of Medicine at the National Institutes of Health. Click on the title of the cited work for more information (this will take you directly to PubMed.gov). Listings go back five years.

1. Utility of insulin-like growth factor receptor-1 expression in gefitinib-treated patients with non-small cell lung cancer.
   Fidler MJ, Basu S, Buckingham L, Walters K, McCormack S, Batus M, Coon J 4th, Bonomi P.
   Anticancer Res. 2012
   2012 May
   32(5):1705-10.
   
2. Prognostic Significance of Weight Gain During Definitive Chemoradiotherapy for Locally Advanced Non-Small-Cell Lung Cancer.
   Sher DJ, Gielda BT, Liptay MJ, Warren WH, Batus M, Fidler MJ, Garg S, Bonomi P.
   Clin Lung Cancer. 2012
   2012 Dec 20. doi:pii: S1525-7304(12)00263-X. 10.1016/j.cllc.2012.10.009. [Epub ahead of print]
   
3. Split-course chemoradiotherapy for locally advanced non-small cell lung cancer: a single-institution experience of 144 patients.
   Gielda BT, Marsh JC, Zusag TW, Faber LP, Liptay M, Basu S, Warren WH, Fidler MJ, Batus M, Abrams RA, Bonomi P.
   J Thorac Oncol.
   2011 Jun
   6(6):1079-86.
   
4. Prognostic value of xanthine oxidoreductase expression in patients with non-small cell lung cancer
   Kim AW, Batus M, Myint R, Fidler MJ, Basu S, Bonomi P, Faber LP, Wightman SC, Warren WH, McIntire M, Arvanitis LD, Gattuso P, Xu X, Liptay MJ
   Lung Cancer
   2011 Feb
   71(2):186-90
   
5. Primary and secondary therapeutic strategies for EGF receptor pathway inhibition in non-small-cell lung cancer
   Batus M, Fidler MJ, Bonomi PD
   Expert Rev Anticancer Ther
   2010 Oct
   10(10):1589-99
   
6. Neoadjuvant treatment of rectal gastrointestinal stromal tumors with imatinib.
   Turner J, Batus M, Leslie W, Coogan C, Saclarides TJ.
   Am Surg.
   2010 Aug
   76(8):E110-2
   
7. Idiopathic hemophagocytic syndrome with a fulminant clinical course
   Khandelwal A, Shah NB, Eichenseer P, Welker M, Miller I, Nangia J, Farhat M, Gimelfarb A, Kassar M, Batus M, Gezer S, Shammo J, Gregory S, Fung H, Venugopal P
   Clin Adv Hematol Oncol
   2008 Aug
   6(8):587-90
   

• To watch a brief video of Marta Batus, MD, click the play button at the lower left corner of the video frame below.
• (If you cannot play the video, you may need to update to the latest version of Adobe Flash Player.)
• View Transcript

• My practice includes very complicated patients — patients mostly with lung cancer, sarcomas and melanoma.

  I’m very committed to my patients, and I think my patients know that. I know it’s very important to not only treat the patient, but also their families. So I also like to include them in the decision making and taking care of the patient as well.

  It’s truly a privilege to be an oncologist, and the most gratifying part of oncology is the patient-physician relationship that we establish with our patients.